Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced it has been selected to present three sessions focused on the real-world impact of treatment decisions on clinical outcomes and total cost of care at the 2019 American Society for Clinical Oncology (ASCO) Annual Meeting, which will take place May 31-June 4 in Chicago.
Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced the launch of PrecisionQ, a suite of solutions designed to help biosciences leaders address the opportunities and challenges presented by the shift in healthcare to value-based care payment models.
New data on the state of value-based care in oncology has found that while community oncologists are optimistic about the beneficial potential of value-based care, they see a conflict between the need to decrease episode costs and the rising prices of the most innovative novel therapies. In an effort to dig deeper into current attitudes toward new value-based reimbursement models and novel therapies in cancer care, Integra Connect surveyed leaders and decision-makers in oncology practices. Respondents represented practices with approximately 530 community oncologists, all of whom are participating in value-based care programs.
Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced that it nearly doubled the number of community oncology providers utilizing solutions connected by its IntegraCloud platform in 2018. These solutions include an oncology EHR; a value-based revenue cycle management (RCM) solution; advanced analytics tools; and a population health management suite. Integra Connect’s user base also now includes one of the largest cohorts of participants in CMS’s groundbreaking alternative payment model program, the Oncology Care Model – numbering approximately 850 providers and 22,000 patients.
Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced that two of the nation’s largest community urology practices are replacing legacy EHRs with Integra Connect’s EHR Solution for Urology: The Urology Group (TUG) and Michigan Institute of Urology (MIU). Together, the groups represent 85 physicians across 34 offices.
ALEXANDRIA, Va. – CancerLinQ LLC announced today that Integra Connect’s EHR Solution for Oncology has been recognized as the first CancerLinQ® Certified Electronic Health Record (EHR) System. CancerLinQ LLC is a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO) that oversees the development and operation of CancerLinQ®, a health information technology platform working to improve quality and value of care for all patients by connecting cancer care team members, researchers, and sponsors with real-world cancer data. In addition, CancerLinQ and Integra Connect have entered into an agreement to collaborate on products and services geared toward improving the quality of cancer care and the access of the CancerLinQ® platform to oncology practices.
Augusta Oncology Goes Live, While Utah Cancer Specialists and Hudson Valley Cancer Center Select Integra Connect’s Technology to Replace Legacy EHRs and Advance High-Quality, Personalized Patient Care
West Palm Beach, FL – Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced partnerships with three of the nation’s pre-eminent independent community oncology practices, who are replacing their legacy EHRs with Integra Connect’s EHR Solution for Oncology. Augusta Oncology, whose eight oncologists provide high-quality, compassionate cancer care across two locations in Georgia, has recently gone live with the Integra Connect EHR solution. […]
Integra Connect Intelligence Unites Disparate Clinical and Financial Data, Enabling Community Oncologists to Predict High-Impact Interventions at Patient and Population Levels
West Palm Beach, FL – Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced the availability of Integra Connect Intelligence, a suite of advanced analytics built specifically for oncology practices increasingly accountable for the cost and quality of cancer care as part of participation in the Oncology Care Model (OCM) and other value-based care programs. […]
56% of Surveyed Providers Recognize Importance of Practice Transformation to Succeed Under New Value-Based Reimbursement Models, Few Making Necessary Investments
West Palm Beach, FL– Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced key findings from its recent survey, the respondents of which represent practices with approximately 800 U.S. specialty physicians. The survey found that a growing number of specialty physicians, comprised mainly of oncologists and urologists, recognize that clinical, financial and operational changes are needed to be successful under value-based care reimbursement models stemming from MACRA regulations. However, the majority have not yet invested in organizational, IT, or service improvements to achieve them. [...]
Partnership will embed the COME HOME program’s triage pathways in Integra Connect’s Oncology Care Model and population health solutions
West Palm Beach, FL and Albuquerque, NM – Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced a partnership with Innovative Oncology Business Solutions (IOBS) to incorporate Community Oncology Medical Home (COME HOME) program triage pathways into its Oncology Care Model (OCM) and population health solutions. Oncology practice staff using Integra Connect solutions will now be able to leverage IOBS’s comprehensive set of protocols to provide aggressive symptom management as part of their patient triage and care coordination workflows, then track and report on results via advanced analytic capabilities. [...]